Editas Medicine (EDIT) Current Leases (2019 - 2025)

Editas Medicine (EDIT) has 7 years of Current Leases data on file, last reported at $6.0 million in Q4 2025.

• On a quarterly basis, Current Leases fell 58.84% year-over-year to $6.0 million in Q4 2025; TTM through Dec 2025 was $6.0 million, a 58.84% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, down 58.84% from the prior year.
• Current Leases for Q4 2025 stood at $6.0 million, down from $6.1 million in the prior quarter.
• Over the last five years, Current Leases for EDIT reached as high as $18.2 million in Q2 2024 and fell as low as $6.0 million in Q4 2025.
• Historically, Current Leases has averaged $10.7 million across 5 years, with a median of $10.3 million in 2021.
• Across the five-year window, Current Leases jumped 76.03% in 2024 and tumbled 66.2% in 2025, its largest moves.
• Year by year, Current Leases stood at $10.3 million in 2021, then gained by 7.5% to $11.1 million in 2022, then advanced by 9.76% to $12.2 million in 2023, then gained by 20.45% to $14.7 million in 2024, then slumped by 58.84% to $6.0 million in 2025.
• Per Business Quant data, the three most recent Current Leases figures were $6.0 million in Q4 2025, $6.1 million in Q3 2025, and $6.1 million in Q2 2025.